Kissei, Purdue terminate diabetes deal

Kissei (Tokyo, Japan) and Purdue Pharma (Norwalk, Conn.) mutually terminated a 1997 deal under which Purdue licensed North and South American rights to Kissei's Mitiglinide ( KAD-1229) oral short-acti...